125 related articles for article (PubMed ID: 38314781)
1. Factors affecting different COVID-19 outcomes in patients with systemic lupus erythematosus during the second pandemic wave of COVID-19 in China.
Liu PC; Zhang M; Li JB; Peng YL; Yu SJ; Wu R
Lupus; 2024 Apr; 33(4):357-364. PubMed ID: 38314781
[TBL] [Abstract][Full Text] [Related]
2. Characteristics associated with poor COVID-19 outcomes in individuals with systemic lupus erythematosus: data from the COVID-19 Global Rheumatology Alliance.
Ugarte-Gil MF; Alarcón GS; Izadi Z; Duarte-García A; Reátegui-Sokolova C; Clarke AE; Wise L; Pons-Estel GJ; Santos MJ; Bernatsky S; Ribeiro SLE; Al Emadi S; Sparks JA; Hsu TY; Patel NJ; Gilbert EL; Valenzuela-Almada MO; Jönsen A; Landolfi G; Fredi M; Goulenok T; Devaux M; Mariette X; Queyrel V; Romão VC; Sequeira G; Hasseli R; Hoyer B; Voll RE; Specker C; Baez R; Castro-Coello V; Maldonado Ficco H; Reis Neto ET; Ferreira GAA; Monticielo OAA; Sirotich E; Liew J; Hausmann J; Sufka P; Grainger R; Bhana S; Costello W; Wallace ZS; Jacobsohn L; Taylor T; Ja C; Strangfeld A; Mateus EF; Hyrich KL; Carmona L; Lawson-Tovey S; Kearsley-Fleet L; Schäfer M; Machado PM; Robinson PC; Gianfrancesco M; Yazdany J
Ann Rheum Dis; 2022 Jul; 81(7):970-978. PubMed ID: 35172961
[TBL] [Abstract][Full Text] [Related]
3. COVID-19 Vaccine Uptake Among Patients With Systemic Lupus Erythematosus in the American Midwest: The Lupus Midwest Network (LUMEN).
Chevet B; Figueroa-Parra G; Yang JX; Hulshizer CA; Gunderson TM; Duong SQ; Putman MS; Barbour KE; Crowson CS; Duarte-García A
J Rheumatol; 2022 Nov; 49(11):1276-1282. PubMed ID: 35777817
[TBL] [Abstract][Full Text] [Related]
4. Risks of mortality and severe coronavirus disease 19 (COVID-19) outcomes in patients with or without systemic lupus erythematosus.
Bruera S; Lei X; Zhao H; Yazdany J; Chavez-MacGregor M; Giordano SH; Suarez-Almazor ME
Lupus Sci Med; 2023 Feb; 10(1):. PubMed ID: 36787921
[TBL] [Abstract][Full Text] [Related]
5. Association Between Race/Ethnicity and COVID-19 Outcomes in Systemic Lupus Erythematosus Patients From the United States: Data From the COVID-19 Global Rheumatology Alliance.
Ugarte-Gil MF; Alarcón GS; Seet AM; Izadi Z; Montgomery AD; Duarte-García A; Gilbert EL; Valenzuela-Almada MO; Wise L; Sparks JA; Hsu TY; D'Silva KM; Patel NJ; Sirotich E; Liew JW; Hausmann JS; Sufka P; Grainger R; Bhana S; Wallace Z; Jacobsohn L; Strangfeld A; Mateus EF; Hyrich KL; Gossec L; Carmona L; Lawson-Tovey S; Kearsley-Fleet L; Schaefer M; Machado PM; Robinson PC; Gianfrancesco M; Yazdany J
Arthritis Care Res (Hoboken); 2023 Jan; 75(1):53-60. PubMed ID: 36239292
[TBL] [Abstract][Full Text] [Related]
6. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
7. Interferon Inhibition for Lupus with Anifrolumab: Critical Appraisal of the Evidence Leading to FDA Approval.
Loncharich MF; Anderson CW
ACR Open Rheumatol; 2022 Jun; 4(6):486-491. PubMed ID: 35157371
[TBL] [Abstract][Full Text] [Related]
8. Latent Tuberculosis Infection and Associated Factors in Patients with Systemic Lupus Erythematosus: a Multicenter, Cross-Sectional Study.
Zhang L; Ma Y; Jiang N; Zou X; Zhang Y; Zhang F; Zeng X; Zhao Y; Liu S; Zuo X; Wu H; Wu L; Li H; Zhang Z; Chen S; Zhu P; Zhang M; Qi W; Liu Y; Liu H; Shi X; Liu X
Microbiol Spectr; 2023 Jun; 11(3):e0084823. PubMed ID: 37158726
[TBL] [Abstract][Full Text] [Related]
9. Health Care-Seeking Behaviors, Disease Progression, Medications, Knowledge of, and Attitudes Toward Systemic Lupus Erythematosus in China: Cross-sectional Survey Study.
Dai Z; Huang X; Yuan F; Li T; Xie B; Lin H; Yang P; Li X; Xu S; Zhao J; Wang Y; Peng X; Wei S; Huang W; Li J; Liang J; Liu X; Chu Y; Zhang Z; Zhang R; Lau EHY; Lin Z
JMIR Public Health Surveill; 2023 Apr; 9():e44541. PubMed ID: 37027203
[TBL] [Abstract][Full Text] [Related]
10. Systemic lupus erythematosus in the light of the COVID-19 pandemic: infection, vaccination, and impact on disease management.
Mehta P; Gasparyan AY; Zimba O; Kitas GD
Clin Rheumatol; 2022 Sep; 41(9):2893-2910. PubMed ID: 35639259
[TBL] [Abstract][Full Text] [Related]
11. COVID-19 prognosis in systemic lupus erythematosus compared with rheumatoid arthritis and spondyloarthritis: results from the CONTROL-19 Study by the Italian Society for Rheumatology.
Scirocco C; Ferrigno S; Andreoli L; Fredi M; Lomater C; Moroni L; Mosca M; Raffeiner B; Carrara G; Landolfi G; Rozza D; Zanetti A; Scirè CA; Sebastiani GD
Lupus Sci Med; 2023 Oct; 10(2):. PubMed ID: 37848262
[TBL] [Abstract][Full Text] [Related]
12. Arthritis and use of hydroxychloroquine associated with a decreased risk of macrophage activation syndrome among adult patients hospitalized with systemic lupus erythematosus.
Cohen EM; D'Silva K; Kreps D; Son MB; Costenbader KH
Lupus; 2018 Jun; 27(7):1065-1071. PubMed ID: 29451069
[TBL] [Abstract][Full Text] [Related]
13. Hesitancy for SARS-CoV-2 vaccines and post-vaccination flares in patients with systemic lupus erythematosus.
Mok CC; Chan KL; Tse SM
Vaccine; 2022 Sep; 40(41):5959-5964. PubMed ID: 36085256
[TBL] [Abstract][Full Text] [Related]
14. Severe pneumonia in Chinese patients with systemic lupus erythematosus.
Peng L; Wang Y; Zhao L; Chen T; Huang A
Lupus; 2020 Jun; 29(7):735-742. PubMed ID: 32403979
[TBL] [Abstract][Full Text] [Related]
15. Invasive fungal infections in Argentine patients with systemic lupus erythematosus.
Vinicki JP; Catalan Pellet S; Pappalardo C; Cruzat VC; Spinetto MA; Dubinsky D; Tiraboschi IN; Laborde HA; Nasswetter G
Lupus; 2013 Aug; 22(9):892-8. PubMed ID: 23861029
[TBL] [Abstract][Full Text] [Related]
16. Clinical features, outcomes and risk factors for posterior reversible encephalopathy syndrome in systemic lupus erythematosus: a case-control study.
Cui HW; Lei RY; Zhang SG; Han LS; Zhang BA
Lupus; 2019 Jul; 28(8):961-969. PubMed ID: 31208267
[TBL] [Abstract][Full Text] [Related]
17. Incidence of COVID-19 Hospitalisation in Patients with Systemic Lupus Erythematosus: A Nationwide Cohort Study from Denmark.
Cordtz R; Kristensen S; Dalgaard LPH; Westermann R; Duch K; Lindhardsen J; Torp-Pedersen C; Dreyer L
J Clin Med; 2021 Aug; 10(17):. PubMed ID: 34501290
[TBL] [Abstract][Full Text] [Related]
18. Systemic Lupus Erythematosus and COVID-19.
Pappa M; Panagiotopoulos A; Thomas K; Fanouriakis A
Curr Rheumatol Rep; 2023 Oct; 25(10):192-203. PubMed ID: 37477841
[TBL] [Abstract][Full Text] [Related]
19. Clinical features of new-onset systemic lupus erythematosus during pregnancy in Central China: a retrospective study of 68 pregnancies.
He X; Jiang D; Wang Z; Li Y; Wang J; Xu D; Chen J; Liu X; Gao G
Clin Rheumatol; 2021 Jun; 40(6):2121-2131. PubMed ID: 33064224
[TBL] [Abstract][Full Text] [Related]
20. Exploring the risk factors for ischemic cerebrovascular disease in systemic lupus erythematosus: A single-center case-control study.
Su L; Qi Z; Guan S; Wei L; Zhao Y
Front Immunol; 2022; 13():978910. PubMed ID: 36238309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
